Clinical Trial

Neoadjuvant Treatment of Locally Advanced HNSCC With Pertuzumab Combined With Lenvatinib.

Name: Neoadjuvant Treatment of Locally Advanced HNSCC With Pertuzumab Combined With Lenvatinib. — clinical trial record (NCT07550972)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Enrolling by Invitation Phase 2

View on ClinicalTrials.gov →

Summary

A single-arm, single-center clinical trial evaluating efficacy (Phase #)

Trial Details

NCT Number	NCT07550972
Lead Sponsor	Zhejiang Provincial People's Hospital
Conditions	Squamous Cell Carcinoma of the Head and Neck
Enrollment	30 participants
Start Date	2026-05-01
Primary Completion	2030-03-31 (estimated)
Study Completion	2030-03-31 (estimated)
Updated on ClinicalTrials.gov	2026-04-24